BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.

Q: What is Black Pearl offering for Selectis Health (OTCQB: GBCS) shares in the 2026 tender offer?

Black Pearl is offering $5.75 per share in cash for all outstanding Selectis Health common stock. According to Black Pearl, this is a cash tender offer, meaning GBCS shareholders would receive cash rather than stock or other consideration if they tender and the offer closes.

Q: When does the Black Pearl tender offer for Selectis Health (GBCS) now expire?

The tender offer now expires at 5:00 p.m. New York City time on August 24, 2026 , unless further extended. According to Black Pearl, the previous August 17, 2026 deadline was extended while the parties work to satisfy remaining conditions to consummate the offer.

Q: How many Selectis Health (GBCS) shares have been tendered to Black Pearl so far?

As of 5:00 p.m. New York City time on August 17, 2026 , 2,769,282 shares had been validly tendered and not withdrawn. According to Black Pearl, this figure was reported to them by Broadridge Corporate Issuer Solutions, which is acting as depositary for the offer.

Q: Why did Black Pearl extend its tender offer for Selectis Health (GBCS) to August 24, 2026?

Black Pearl extended the tender offer to August 24, 2026 to allow more time to satisfy conditions required for consummation. According to Black Pearl, all other terms and conditions of the tender offer remain unchanged despite the revised expiration date.

Q: Who are the key agents involved in the Black Pearl tender offer for Selectis Health (GBCS)?

Laurel Hill Advisory Group is the information agent , handling shareholder inquiries and materials requests. Broadridge Corporate Issuer Solutions is the depositary , receiving and holding tendered shares. According to Black Pearl, Selectis shareholders can contact Laurel Hill by toll-free phone or email for tender documents.

Q: Where can Selectis Health (GBCS) shareholders find official documents about the Black Pearl tender offer?

Shareholders can access the Schedule TO , Offer to Purchase , and Selectis’ Schedule 14D-9 on the SEC’s website at www.sec.gov . According to Black Pearl, additional copies can also be requested from Laurel Hill Advisory Group, the information agent, free of charge.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Black Pearl Equities extended the expiration of its cash tender offer to purchase all outstanding shares of Selectis Health (OTCQB: GBCS) at $5.75 per share. The offer, previously set to end on August 17, 2026, will now expire at 5:00 p.m. New York City time on August 24, 2026, unless further extended, while conditions to closing continue to be addressed.

According to Black Pearl, 2,769,282 shares had been validly tendered and not withdrawn as of August 17, 2026. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is serving as depositary for the tender offer.

Positive

All-cash offer at $5.75 per share for all outstanding GBCS shares
Expiration extended to August 24, 2026, giving shareholders more time to tender
2,769,282 shares already validly tendered and not withdrawn as of August 17, 2026

Negative

Offer remains subject to conditions that are still being worked on before consummation
Tender offer end date extended by one week, indicating a longer timeline to potential closing

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/18/2026 - 10:02 AM

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Black Pearl Equities, a New York-based investment group (together with its affiliates, "Black Pearl"), today announced that it has extended the expiration date of its previously announced tender offer to purchase all of the outstanding shares of common stock of Selectis Health, Inc. (OTCQB: GBCS) ("Selectis" or the "Company"), a healthcare company, for $5.75 per share in cash.

The tender offer, which was scheduled to expire at 5:00 p.m., New York City time, on August 17, 2026, has been extended and will now expire at 5:00 p.m., New York City time, on August 24, 2026, unless further extended, as the parties continue to work to satisfy certain conditions to the consummation of the offer. All other terms and conditions of the tender offer remain unchanged.

The information agent for the tender is Laurel Hill Advisory Group. Selectis stockholders who need additional copies of the Offer to Purchase, Letter of Transmittal or related materials, or who have questions regarding the tender offer, should contact the information agent toll free at (844) 305-2265 or by email at GBCS@laurelhill.com.

Broadridge Corporate Issuer Solutions, LLC ("Broadridge") is acting as depositary for the tender offer. Broadridge has advised Black Pearl that, as of 5:00 p.m., New York City time, on August 17, 2026, 2,769,282 shares had been validly tendered and not withdrawn from the tender offer.

Important Information

This press release is for informational purposes only and it is neither an offer to purchase nor a solicitation of an offer to sell shares of Selectis' common stock. Black Pearl has filed a Tender Offer Statement on Schedule TO, containing an Offer to Purchase, a form of Letter of Transmittal and other related tender offer documents with the U.S. Securities and Exchange Commission (the "SEC"), and Selectis has filed a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Selectis' stockholders are strongly advised to read these tender offer materials carefully and in their entirety as they become available, as they may be amended from time to time, because they contain important information about the tender offer that Selectis' stockholders should consider prior to making any decisions with respect to the tender offer. Once filed, Selectis' stockholders will be able to obtain a free copy of these documents at the website maintained by the SEC at www.sec.gov or by directing a request to the information agent toll free at (844) 305-2265.

Forward-Looking Statements

This press release contains "forward-looking statements". Forward-looking statements can be identified by words like "may," "will," "likely," "should," "expect," "anticipate," "future," "plan," "believe," "intend," "goal," "seek," "estimate," "project," "continue," and variations of such words and similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, assumptions, and uncertainties, including, but not limited to, risks related to: (i) the satisfaction of the conditions to closing the transaction in the anticipated timeframe or at all; (ii) the failure to obtain necessary regulatory approvals; (iii) the ability to realize the anticipated benefits of the transaction; (iv) the ability to successfully integrate the businesses; (v) disruption from the transaction making it more difficult to maintain business and operational relationships; (vi) the negative effects of this announcement or the consummation of the proposed transaction on the market price of Selectis' common stock; (vii) significant transaction costs and unknown liabilities; (viii) litigation or regulatory actions related to the proposed transaction; and (xi) the failure to obtain the necessary financing to complete the transaction. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

The forward-looking statements included in this press release are made only as of the date of this release, and except as otherwise required by federal securities law, neither Selectis nor Black Pearl assumes any obligation nor do they intend to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

About Selectis Health, Inc.

Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market.

Contact

Selectis Health, Inc.
600 17th Street, Suite 2800
Denver, CO 80202

About Black Pearl

Black Pearl is a dynamic investment firm, advisory, and consultancy strategically diversified across healthcare sectors. Headquartered in Brooklyn, New York, Black Pearl fosters strategic synergies and facilitates high-impact transactions.

Contact

Anthony Vitellozzi
Laurel Hill Advisory Group
(844) 305-2265
GBCS@laurelhill.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/black-pearl-extends-tender-offer-for-all-outstanding-shares-of-selectis-health-inc-302854191.html

SOURCE Black Pearl Equities

FAQ

What is Black Pearl offering for Selectis Health (OTCQB: GBCS) shares in the 2026 tender offer?

Black Pearl is offering $5.75 per share in cash for all outstanding Selectis Health common stock. According to Black Pearl, this is a cash tender offer, meaning GBCS shareholders would receive cash rather than stock or other consideration if they tender and the offer closes.

When does the Black Pearl tender offer for Selectis Health (GBCS) now expire?

The tender offer now expires at 5:00 p.m. New York City time on August 24, 2026, unless further extended. According to Black Pearl, the previous August 17, 2026 deadline was extended while the parties work to satisfy remaining conditions to consummate the offer.

How many Selectis Health (GBCS) shares have been tendered to Black Pearl so far?

As of 5:00 p.m. New York City time on August 17, 2026, 2,769,282 shares had been validly tendered and not withdrawn. According to Black Pearl, this figure was reported to them by Broadridge Corporate Issuer Solutions, which is acting as depositary for the offer.

Why did Black Pearl extend its tender offer for Selectis Health (GBCS) to August 24, 2026?

Black Pearl extended the tender offer to August 24, 2026 to allow more time to satisfy conditions required for consummation. According to Black Pearl, all other terms and conditions of the tender offer remain unchanged despite the revised expiration date.

Who are the key agents involved in the Black Pearl tender offer for Selectis Health (GBCS)?

Laurel Hill Advisory Group is the information agent, handling shareholder inquiries and materials requests. Broadridge Corporate Issuer Solutions is the depositary, receiving and holding tendered shares. According to Black Pearl, Selectis shareholders can contact Laurel Hill by toll-free phone or email for tender documents.

Where can Selectis Health (GBCS) shareholders find official documents about the Black Pearl tender offer?

Shareholders can access the Schedule TO, Offer to Purchase, and Selectis’ Schedule 14D-9 on the SEC’s website at www.sec.gov. According to Black Pearl, additional copies can also be requested from Laurel Hill Advisory Group, the information agent, free of charge.